Inicio>>Signaling Pathways>> Membrane Transporter/Ion Channel>> Sodium Channel>>PF-05089771 (tosylate)

PF-05089771 (tosylate)

Catalog No.GC18947

PF-05089771 (tosilato) es un inhibidor de arilsulfonamida Nav1.7 potente, activo por vía oral y selectivo, con valores IC50 de 11 nM, 12 nM, 13 nM, 171 nM y 8 nM para hNav1.7, cynNav1.7, dogNav1.7 ,ratNav1.7 y musNav1.7, respectivamente.

Products are for research use only. Not for human use. We do not sell to patients.

PF-05089771 (tosylate) Chemical Structure

Cas No.: 1430806-04-4

Tamaño Precio Disponibilidad Cantidad
5mg
138,00 $
Disponible
10mg
262,00 $
Disponible
25mg
548,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products
PF-05089771 is a voltage-gated sodium channel 1.7 (Nav1.7) blocker (IC50s = 11, 16, 33, and 20 nM for 5N11S, 5A11L, 5A11S, and 5A11L Nav1.7 splice variants, respectively). It is selective for Nav1.7 over Nav1.1-1.6 and 1.8 channels (IC50s = 0.11-25 μM), L-type calcium, and KvLQT and hERG potassium channels (IC50s =>10 μM), as well as human and cynomolgus monkey TRPV1 receptors (IC50s = 10 and 20 μM, respectively). PF-05089771 is also 1,000-fold selective for half-inactivated over resting Nav1.7 channels, and mutation of the domain IV voltage-sensor domain (VSD4) reduces PF-05089771 potency by approximately 100-fold.

Reseñas

Review for PF-05089771 (tosylate)

Average Rating: 5 ★★★★★ (Based on Reviews and 24 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for PF-05089771 (tosylate)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.